Résultat pour le terme : small molecule
Gladius nouvel essai blog neomed

(audio-EN) Gladius Pharmaceuticals closes a $4,1 million Series A for its new generation of antibiotics

Montreal (QUEBEC) – After a year of negotiations, the newly created company Gladius Pharmaceuticals has successfully raised $4,1 million in a Series A financing. In this interview, Michael Atkin, CEO of Gladius, explains how he got in touch with the prestigious investors that participated in the operation, including Lumira Capital, SR One and Fonds de solidarité […]